SCHEMBL23017937

SCHEMBL23017937

C=Cc1ccc(Br)cc1OCc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCR5 P51681 6/20 0.50
▸ SLC6A4 P31645 1/20 0.50
▸ MAOB P27338 2/20 0.49
▸ PTPN1 P18031 1/20 0.47
▸ LMNA P02545 2/20 0.46
▸ USP2 O75604 1/20 0.46
▸ ALDH1A1 P00352 3/20 0.46
▸ RAB9A P51151 2/20 0.46
▸ USP28 Q96RU2 1/20 0.46
▸ USP25 Q9UHP3 1/20 0.46
▸ PTP4A3 O75365 1/20 0.45
▸ HTT P42858 2/20 0.45
▸ NPC1 O15118 1/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ RECQL P46063 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4427861 0.84 CCR5 (0.50) CCR5SLC6A4MAOBPTPN1LMNA
SCHEMBL15056732 0.82 CCR5 (0.48) CCR5SLC6A4MAOBPTPN1LMNA
SCHEMBL15056730 0.82 CCR5 (0.48) CCR5SLC6A4MAOBPTPN1LMNA
SCHEMBL20359857 0.81 MAPT (0.49) MAOBLMNAALDH1A1RAB9AHTT
SCHEMBL31644088 0.80 SLC6A4 (0.66) CCR5SLC6A4MAOBLMNAALDH1A1
SCHEMBL368071 0.80 SLC6A4 (0.66) CCR5SLC6A4MAOBLMNAALDH1A1
SCHEMBL1029072 0.80 CCNB2 (0.62) ALDH1A1RAB9AHTTNPC1CYP1A2
SCHEMBL4430797 0.80 MAOB (0.60) CCR5SLC6A4MAOBLMNAUSP2
SCHEMBL4430794 0.80 MAOB (0.60) CCR5SLC6A4MAOBLMNAUSP2
SCHEMBL13886069 0.80 MAOB (0.60) CCR5SLC6A4MAOBLMNAUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3782995-B1 SPIRO CONDENSED IMIDAZOLINE-2,4-DIONE DERIVATIVES AS HISTONE ACETYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF CANCER DISEASES SHANGHAI INST MATERIA MEDICA CAS (CN) 2023-11-22 — — EP disclosed
EP-3782995-A1 HISTONE ACETYLTRANSFERASE (HAT) INHIBITOR AND USE THEREOF Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) 2021-02-24 — — EP disclosed
Send feedback